Keywords
insulin growth factor type 1 (IGF-1)
vitamin D
parathyroid hormone (PTH)
growth
How to Cite
Abstract
Introduction: Growth delay has been described in children with juvenile idiopathic arthritis (JIA). Low vitamin D and insulin growth factor type 1 ( IGF-1) have been reported in this disease and seem to be related to the inadequete bone development and subsequent growht delay.
Objetive: To determine growth status, levels of IGF-1, and Vitamin D in patients with JIA, acording to JIA subtype, received treatment, disease duration, age and gender of each patient.
Methods: Thirteen (13) children with JIA were included in this cohort sutdy . Patients were seen on an ambulatory basis from february through may of 2019 . They recevied a clinical and anthropometric evaluation and serum was collected for Vitamin D[25(OH)D], IGF-1 and PTH measurement through chemiluminescent immunoessays. Growth charts approved by the CDC were also used to determine the patients’ growth status.
Results and discussion: Vitamin D insuficiency was observed in 84,62% of patients , including those wiht growth delay (15,38%). Accordin to different authors, this could be a cause of such delay, but we are unable to draw conclusions with this study. Insulin growth factor 1 (IGF-1) was normal in all patients. Use of corticosteroids, disease duration, JIA subtype or treatment, age and gender were not found to be implicated as risk factors for growth delay.
Conclusion: Growth delay was found in 15,38% of the patientes. Significant Vitamin D insuficiency was identified in patients with JIA, which suggest that further studies might identify variables that might correlated with this deficit.
References
(1) Sociedad española de reumatología pediátrica. Los niños también sufren enfermedades reumatológicas [Internet]. Gebro pharma. 2017 [citado 18 feb 2019]. Disponible en: https://lligareumatologica.org/los-ninos-tambien-sufren-enfermedades-reumatologicas/
(2) Urbaneja Rodríguez E, Solís Sánchez P. Artritis idiopática juvenil. Pediatría Integral. 2017;21(3):170–82.
(3) Bechtold S, Simon D. Growth abnormalities in children and adolescents with juvenile idiopathic arthritis. Rheumatol Int. 2014;34(11):1483–8.
(4) Fundación Española de Reumatología. Fármacos Modificadores de la Enfermedad (FARME) [Internet]. 2018 [citado 6 mar 2019]. Disponible en: https://inforeuma.com/tratamientos/tipos-de-tratamientos/farmacos-modificadores-de-la-enfermedad-fame/
(5) López-gonzález D, Méndez-sánchez L. Deficiencia de vitamina D en la edad pediátrica. una oportunidad de prevención. Bol Med Hosp infant Mex. 2015;72(4).
(6) Finch SL, Rosenberg AM, vatanparast H. vitamin D and juvenile idiopathic arthritis. Pediatr Rheumatol. 2018;16(1).
(7) International Journal of Rheumatic Diseases. Disease flare after 7 year-remission of systemic type juvenile idiopathic arthritis: ¿is growth hormone therapy a culprit or innocent bystander? int Jou of Rheumato Dis [Internet]. 2015 [citado 29 feb 2019];18(3):377–8.
(8) Lundell A, Erlandsson M, Bokarewa M, Liivamägi H, uibo K, Tarraste S, et al. Low Serum iGF-1 in Boys with Recent Onset of Juvenile idiopathic Arthritis. Hindawi. 2018;1-10.
(9) Fundación universitaria iberoamericana. La parathormona y su relación con la vitamina D [Internet]. Funiber. 2009 [actualizado 2019; citado 5 may 2019]. Disponible en: https://blogs.funiber.org/salud-y-nutricion/2009/11/30/la-parathormona-y-su-relacion-con-la-%20vitamina-d
(10) Nisar MK, Masood F, Cookson P, Sansome A, Östör AJK. What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidence. Clin Rheumatol. 2013; 32:729–734.
(11) Hernández v, Duarte C, Maldonado R, Rivas R. Determinación de concentraciones séricas de 25 (OH) D en niños con lupus eritema- toso sistémico y artritis idiopática juvenil. Bol Med Hosp infant Mex [internet]. 2015 [citado 18 feb 2019]; 72(2):99–105. Disponible en: http://dx.doi.org/10.1016/j.bmhimx.2015.05.002
(12) Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the united States: Methods and development. National Center for Health Statistics. vol 11. Washington, DC: vital Health Stat; 2002
(13) CDC: Centers for Disease Control and Prevention. 2 a 20 años: Niñas Percentiles de Estatura por edad y Peso por edad. Cent Nac estadísticas salud [Internet]. 2000 [citado 8 mayo 2019]. Disponible en: www.cdc.gov/growthcharts
(14) CDC: Centers for Disease Control and Prevention. 2 a 20 años: Niños Percentiles de Estatura por edad y Peso por edad. Cent Nac estadísticas salud [internet]. 2000 [citado 8 mayo 2019]. Disponible en: www.cdc.gov/growthcharts
(15) IBM Corp. IBM SPSS Statistics (versión 25.0) [Software]. Armonk, NY: IBM Corp; 2017.
(16) Nobre C, Júnior R, Melo R De. vitamin D levels in juvenile idiopathic arthritis from an equatorial region. Rheumatol Int. 2015; 35:1717–23.
(17) Çomak E, Doğan ÇS, Uslu-gökçeoğlu A, Akbaş H, Özdem S. Association between vitamin D deficiency and disease activity in juvenile idiopathic arthritis. The Turkish Journal of Pediatrics. 2014; 56:626–31.
(18) Bouaddi I, Rostom S, Badri D El, Hassani A, Chkirate B, Abouqal R. vitamin D concentrations and disease activity in Moroccan child- ren with juvenile idiopathic arthritis. BMC Musculoskeletal Disorders. 2014; 15:115-9.